18
Quick Investors Reference Guide to Regulated Medical Device & Digital Health Space 1 Braingels 2016

Physio-Logic-InvestorsRegulatoryPerspective

Embed Size (px)

Citation preview

Page 1: Physio-Logic-InvestorsRegulatoryPerspective

Quick Investors Reference Guide

to Regulated Medical Device &

Digital Health Space

1

Braingels 2016

Page 2: Physio-Logic-InvestorsRegulatoryPerspective

This presentation is the sole property of Physio-logic Ltd and is protected by Copyright ©. Any use of this presentation without the prior written approval of Physio-Logic Ltd is prohibited. This presentation does not constitute regulatory advice and should not be regarded as replacing professional consultation. We recommend that you receive specific professional advice in relation to any regulatory matter.

What does regulation stands for? How does it impact me? Tips & pearls Digital vs. non digital MD regulation in a nutshell

2

Page 3: Physio-Logic-InvestorsRegulatoryPerspective

Barrier to Market

It Comes with the Territory…

Typically attributed to product approval by regulatory agencies (FDA, CE, AMAR etc.)

Extends to the entire lifecycle of medical device from inception to end of life

A collective name for three disciplines: Regulatory Affairs (RA) Quality Affairs (QA & QC) Clinical Affairs (CA)

What Does Regulation Stands for? 3

Page 4: Physio-Logic-InvestorsRegulatoryPerspective

Is my product regulated as Medical device?

What is its classification?

Which regulatory requirements apply to my product?

What is my time to market?

How much will it cost me?

Start up wisdom, innovation, leverage good regulatory science and medicine

QRC Strategy & Work-plan

What Does Regulation Stands for? 4

Page 5: Physio-Logic-InvestorsRegulatoryPerspective

It Impacts Your ROI

Page 6: Physio-Logic-InvestorsRegulatoryPerspective

The Impact –Early Stage

How Does it Impact Me?6

Betting on the “wrong horse” Time to market Do it right the first time:

Q: Are we developing the right product? A: Due-dilligence; QA & CA feed the answer

Q: Are we developing the right product right? A: Design control practice, Quality by design

Wrong doing, under doing, over doing

burn rate, dilution…diminsh ROI

Page 7: Physio-Logic-InvestorsRegulatoryPerspective

Increase Your ROI

How Does it Impact Me?7

Valid Regulatory strategy Clinical strategy Quality plan Gates Control

Page 8: Physio-Logic-InvestorsRegulatoryPerspective

Bottom Up QRC Work-plan & Budget

How Does it Impact Me?8

Harmonized with R&D WP

Manage your risk

Time to market

Burn rate

ROI

Page 9: Physio-Logic-InvestorsRegulatoryPerspective

Compliance (Late Stage)

How Does it Impact Me?9

Page 10: Physio-Logic-InvestorsRegulatoryPerspective

Tips & Pearls

How Does it Impact Me?10

Due diligence: screen strategy – is QRC project risk aligned with your investment strategy, are project plan and budget valid?

Control your investment – do it right the first time

Understand that ensuring your project is handled by competent QRC expert is in your best interest as investor

Page 11: Physio-Logic-InvestorsRegulatoryPerspective

Three risk classes Risk vs. benefit Intended use General controls, special controls and PMA

Medical Device Regulation

11Digital Health Regulation

Four classes driven by risk and classification rules Loosely tied to intended use Conformity assessment

Paradigm more established but struggling with innovation

Page 12: Physio-Logic-InvestorsRegulatoryPerspective

Digital Health Regulation is Challenging

• Regulation is (always) behind technology

• Booming health apps. Nd Health IT products

• Multiple stake holders (HIPPA, FD&C Act, FTC Act, CMS)

• Multiple types (mHealth, CDS, Health IT, Personalized Medicine, Telemedicine, wearable device (IOT))

• The demarcation between FDA regulated product vs. nonregulated is complex and tricky at times.

• The ramifications of this demarcation are extensive!

12

Page 13: Physio-Logic-InvestorsRegulatoryPerspective

Risk (privacy, hacking, injury, miss-diagnosis, delay of treatment, misuse, error)

Functionality focused (administrative, medical device etc.)

Narrowly tailored

Risk Based Approach for Regulating Digital Health

13

Page 14: Physio-Logic-InvestorsRegulatoryPerspective

Regulation Goes Beyond FDA

FCC, RTTE

FTC

HIPPA (Privacy, Security)

EC Privacy directive (95/46/EC)

ISO/IEC Health IT Standards

Liability for defective products (1985/374/EC &1999/34/EC)

General product safety (2001/95/EC)

Sale of consumer goods (1999/44/EC)

and much more…..

Page 15: Physio-Logic-InvestorsRegulatoryPerspective

Our Mission Statement

Successfully Navigating the Regulatory

Maze

Page 16: Physio-Logic-InvestorsRegulatoryPerspective

Founded & Managed by Gadi Ginot

• Over 20 years industry experience in managing

Medical Device & Combination product regulation,

quality and clinical development

Pharma (Teva)

Medical Device

International experience (scores of relocation to

the EU, US)

• Internationally renown

• Unprecedented accomplishment in navigating precut

certification thru FDA and Notified Body

Page 17: Physio-Logic-InvestorsRegulatoryPerspective

Full Service Solution for Medical Device Manufacturer

• Largest vendor in Israel (over 30 experts on board)• We cover all bases of Medical Device• Designated Digital Health Team

Usability FDA 513(g), 510(k), PMA CE Mark ISO13485, ISO9001, CMDCAS CLIA International registration

including AMAR, Russia, CFDA Compliance

HW & SwQA Design Control Risk Management Performance

evaluation Clinical evaluation Clinical Trials HIPPA Cybersecurity

Page 18: Physio-Logic-InvestorsRegulatoryPerspective

Gadi Ginot: [email protected]

050-8317449

www.physio-logic.co.il18